What are the new SEC supplier financing disclosure rules, and what do they tell investors?

In 2023, the SEC took an unprecedented step by requiring public companies to disclose the extent to which they finance their supply chains through extended payment terms or supplier financing programs. The rule change reflected a growing concern that companies were quietly shifting their working capital burden onto suppliers—often smaller, weaker businesses with less bargaining power—while appearing to generate strong cash flow. What looks like operational excellence on a company's cash flow statement can mask a harsh reality: suppliers are being squeezed, and the company's reported cash health is partly illusory.

This disclosure requirement shines a spotlight on one of the murkiest corners of corporate finance. Understanding what these disclosures reveal, how to find them, and what they signal about underlying business health is now essential for any investor serious about cash flow quality.

Quick definition

Supplier financing refers to programs in which a company extends payment terms beyond standard industry practice or uses third-party financial institutions to finance its suppliers' operations. Examples include open payment terms of 60, 90, or 120 days (vs. standard 30-45 days), supply chain financing platforms where suppliers can sell receivables at a discount to financial institutions, and reverse factoring arrangements where a finance company purchases the company's payables and allows suppliers to receive cash earlier at a discount. All of these effectively shift working capital burden from the company to its suppliers, artificially improving the company's operating cash flow and balance sheet.

Key takeaways

• The SEC's new disclosure rules require companies to disclose the dollar amount and terms of supplier financing programs, revealing a hidden source of cash flow improvement
• Supplier financing can be legitimate supply chain management, but aggressive programs often mask working capital games and damage supplier relationships
• The amount and growth rate of supplier financing outstanding is a red flag for working capital manipulation
• Suppliers who cannot afford to sell receivables at a discount to finance companies are effectively forced into interest-free loans to large corporate customers
• Companies with strong pricing power and healthy operations rarely need extensive supplier financing programs
• Comparing supplier financing data across competitors reveals which companies are truly operationally excellent and which are shifting burden onto suppliers

The SEC disclosure requirement and what triggered it

For decades, companies could extend supplier payment terms or create complex supplier financing programs without disclosing the extent or impact on cash flow. Apple, for instance, famously extended payment terms to suppliers from 30 days to 90 days or more, freeing up billions in cash. But the company never disclosed the dollar amount of this arrangement or how it compared to competitors' practices.

The SEC began noticing in 2020-2022 that some companies were reporting strong operating cash flow while simultaneously extending supplier payment terms. The divergence was suspicious: if the company's underlying business was not deteriorating, why did suppliers need more time to get paid? The answer, the SEC concluded, was that some companies were systematically shifting working capital onto suppliers as a financial engineering tactic.

In October 2023, the SEC adopted rules requiring Item 6 of quarterly and annual reports to disclose:

• The total dollar amount of supplier financing arrangements outstanding
• The percentage of accounts payable financed through these programs
• Material changes in these amounts quarter-over-quarter
• The terms, conditions, and economic impact of the programs

Disclosure is required if the amounts are material (roughly 5% of accounts payable or higher). The rules took effect for fiscal years ending on or after December 15, 2024, and are now visible in most 10-Ks and 10-Qs filed in 2025 and beyond.

Types of supplier financing programs

Open payment terms. The simplest and most common form. A large company tells suppliers "you have 90 days to get paid instead of 30." This inflates the company's operating cash flow by tens or hundreds of millions of dollars in a single stroke. It is disclosed passively if at all, often buried in MD&A language like "we have optimized our payment cycles." Now it must be disclosed explicitly.

Supply chain financing platforms. The company works with a financial services provider (typically a bank or fintech) to offer suppliers the option to sell their receivables to the finance company at a discount, receiving cash immediately. The finance company then collects from the company on the normal (extended) payment terms. For example:

• Supplier delivers goods; company owes $1 million due in 90 days.
• Supplier uses the platform to sell the receivable to the finance company for $980,000.
• Supplier receives $980,000 immediately; finance company waits 90 days to collect from the company.
• The $20,000 discount compensates the finance company for the 90-day float.

To the company, this looks clean: the platform transfers the supplier's working capital burden to a third party. But in reality, the company has not eliminated the burden; it has simply shifted it. Suppliers small enough to need immediate cash suffer an implicit tax (the $20,000 discount) to accommodate the large company's extended payment terms.

Reverse factoring. Similar to supply chain financing but structured differently. The company's bank confirms that the company will pay on the extended terms (90 days). Suppliers can then present this "confirmed payable" to the bank for immediate cash, minus a modest fee (2-4% annually). Reverse factoring is sometimes called "supply chain financing optimized" and is popular among large companies with strong credit ratings.

Inventory financing programs. The company arranges financing for suppliers to build inventory, which the company then purchases. This is less common than payment term extensions but exists in capital-intensive industries like automotive and semiconductors.

How supplier financing inflates operating cash flow

On the cash flow statement, supplier financing creates a false impression of strong cash generation. Here is the mechanics:

Without supplier financing:

• Company records revenue: $100 million
• Company pays suppliers in 30 days: $70 million
• Operating cash flow (simplified): $30 million

With supplier financing (extending terms to 90 days):

• Company records revenue: $100 million
• Company pays suppliers in 90 days: $70 million (no immediate cash outlay)
• Operating cash flow (simplified): $30 million + $70 million = $100 million (or more, if other factors align)

The difference in cash timing is dramatic. By stretching payables, the company appears to generate an extra $70 million in cash in the first quarter. But this is not new cash; it is borrowed cash from suppliers. In the second quarter, the company will pay that $70 million, creating a matching headwind in the cash flow statement.

If the company renews supplier financing each quarter (always extending terms), it can perpetually defer the $70 million cash outlay. This is mathematically equivalent to a permanent, interest-free loan. The cash flow benefit becomes structural, not temporary.

The SEC's new disclosure rules allow investors to see exactly how much of this "structural" financing is outstanding and whether it is growing faster than revenue.

Red flags in supplier financing disclosures

Supplier financing as a percentage of accounts payable. If a company discloses that $2 billion of its $5 billion in accounts payable are financed through supplier programs, that is 40%—a massive proportion. For comparison, healthy companies typically finance 5-15% of payables through these programs. Anything above 25% warrants scrutiny.

**Rapid growth in supplier financing.**If supplier financing doubles year-over-year while revenue grows only 10%, the company is not managing suppliers better; it is squeezing them harder. This growth rate is unsustainable; eventually, suppliers will run out of willingness or ability to accept extended terms, and the company will be forced to normalize payment schedules, creating a negative cash flow shock.

Supplier financing growing faster than payables overall. If accounts payable grew 5% but supplier financing programs grew 25%, the composition of payables has shifted toward stretched suppliers. This is a sign of increasing reliance on working capital management rather than operational improvement.

Lack of transparency on terms and conditions. The SEC requires disclosure of "material changes" in terms. If a company's disclosure is boilerplate ("we have optimized supplier payment arrangements to improve cash management"), demand more detail in earnings calls or investor meetings. What changed? What are the average payment terms? How much higher than prior year?

Programs involving small suppliers without direct access to capital markets. Reverse factoring is often marketed as "supplier-friendly," but it can be painful for small suppliers. If a supplier cannot secure 2-4% annual financing elsewhere, the reverse factoring arrangement looks like a tax. The company is, in effect, charging small suppliers for the privilege of paying on extended terms.

Disclosure buried in the 10-K or missing entirely. Some companies disclose supplier financing in Item 6 or Item 7 of the 10-K (MD&A), but make it hard to find. If you have to read 50 pages of fine print to locate this number, the company is not keen on transparency. Cross-check the 10-Q; if the disclosure appears in the 10-K but is missing from quarterly filings, that is suspicious.

Comparing supplier financing across competitors

The power of the SEC's disclosure rule is comparative. For the first time, investors can compare how much large companies rely on supplier financing.

Example: Two semiconductor equipment manufacturers, both with $20 billion in revenue:

Company A:

• Accounts payable: $6 billion
• Supplier financing: $300 million (5% of payables)

Company B:

• Accounts payable: $7 billion
• Supplier financing: $1.5 billion (21% of payables)

Company B is relying far more on supplier financing. If both companies report similar operating cash flow improvements, but Company B achieves its improvement through supplier financing while Company A achieves it through operational efficiency, Company A is the stronger business. Company B's suppliers are likely experiencing payment stress that will eventually force a normalization.

This comparison works even better over time. If Company B's supplier financing grows to 30% of payables over three years while Company A's remains flat at 5%, investors can conclude that Company B's cash flow "improvement" is partly illusory and dependent on sustained supplier cooperation.

The economic harm to suppliers

Supplier financing programs, while legal and now disclosed, impose real costs on suppliers:

Implicit interest cost. If a supplier can normally finance itself at 3% per annum but must use supply chain financing costing 4%, the extra 1% is a tax paid to the large company. Across an industry, this compounds supplier margins downward.

Credit constraint. A small supplier might be able to borrow $1 million from its own bank at 3% per annum. But if its largest customer extends payment terms from 30 to 90 days, the supplier needs $2-3 million in financing just to accommodate that one customer. The supplier may lack the credit capacity to finance both its own growth and the customer's extended terms. The result: the supplier underinvests in R&D, capital improvements, or hiring, effectively ceding innovation to competitors with better-capitalized supply bases.

Negotiating leverage loss. Suppliers with poor cash positions are weaker negotiators. They cannot afford to walk away from deals or demand better terms. This often leads to one-way renegotiations, where the large company extracts price cuts or higher quality standards at the supplier's expense.

Industry consolidation. Smaller suppliers that cannot afford extended-term financing are forced out of business, while only the largest, most capitalized suppliers survive. Over time, supply bases consolidate, and large companies lose the benefits of a diverse, competitive set of vendors. Quality suffers; innovation slows.

Legitimate uses of supplier financing

Not all supplier financing is manipulative. Some legitimate uses include:

Seasonal business cycles. A retailer with heavy holiday season purchasing may offer extended terms to suppliers to smooth cash flow across the year. This is efficient for both parties.

Infrastructure investment. A company building a new factory might extend supplier terms to preserve cash for capex. If the investment improves long-term cash flow, the temporary term extension is justified.

Supplier strength and stability. A large automotive company might offer extended terms to a key supplier to help that supplier invest in new equipment or technology. The company benefits from a stronger, more reliable supply base. This is mutually beneficial.

Scale leverage. A company with billions in revenue can access capital markets at 2% per annum. It might offer to finance a supplier's inventory at 2.5%, a better rate than the supplier could get alone. Both parties save money.

The distinguishing factor: In legitimate cases, the supplier financing program is transparent, mutual, and sustainable. Both the company and the supplier benefit. In manipulative cases, the program is hidden, extractive, and dependent on perpetual expansion (rolling forward each quarter).

Red flags in specific industries

Retail. Large retailers like Walmart are infamous for extending payment terms. A Walmart supplier might wait 120+ days to get paid. The disclosure rules now reveal the scale of this practice. Retailers with supplier financing exceeding 15% of payables should be questioned about competitive sustainability.

Technology and software. Companies like Apple and Microsoft have been masterful at extending supplier payment terms while maintaining strong supplier relationships through volume and scale. But excessive supplier financing (above 20% of payables) suggests the supplier base is being squeezed beyond the point of goodwill.

Automotive. Toyota and other automakers use supplier financing extensively, but with good reason: they have massive inventory pipelines and need to manage parts suppliers' cash flow. However, sudden changes in supplier financing terms can signal inventory troubles or slowing demand.

Pharmaceutical and medical device. Hospitals and pharmacy benefits managers often stretch payments to pharma suppliers. When pharma companies extend their own supplier terms in response, it cascades down the supply chain. Disclosure of this trickle-down effect is valuable.

How to dig deeper once you spot red flags

If you see supplier financing disclosure that raises concerns:

1. Check the MD&A for context. Look for language explaining why supplier financing exists, how terms are set, and whether the program is expanding or contracting. If the company says "we have optimized our cash conversion cycle," that is vague. Push for specifics.

2. Compare to peers. Pull the same disclosure from 2-3 competitors. Calculate supplier financing as a percentage of accounts payable for each. If your company is an outlier, investigate why.

3. Trend it over time. If you have access to prior-year 10-Ks, calculate supplier financing as a percentage of payables for the last 2-3 years. If the percentage is rising, especially faster than revenue growth, the company is increasingly reliant on supplier financing. This is unsustainable.

4. Ask in earnings calls. Post a question to management: "What is the breakdown of supplier financing programs by geography and supplier size? How much of supplier financing is extended to small suppliers versus large ones?" The answer will reveal whether the company is squeezing vulnerable suppliers or maintaining balanced terms with all partners.

5. Monitor supplier turnover. If a company's supplier base begins turning over at higher rates (suppliers are replaced more frequently), that can signal payment term stress. This is not always disclosed, but sector intelligence (trade press, supplier surveys) can reveal it.

Case studies

Apple's supplier financing dominance. Apple disclosed in its 2024 10-K that supplier financing programs represent approximately 20% of its accounts payable, a figure that has grown consistently over the past three years. While Apple maintains excellent supplier relationships and has invested in supplier development programs, the scale of this financing suggests that many suppliers operate with extended payment cycles necessary to support Apple's cash flow management.

Costco's lean approach. Costco discloses minimal supplier financing, typically less than 3% of accounts payable. This reflects Costco's own strong operating cash flow generation and its commitment to quick payment cycles. This builds loyalty among suppliers and supports a competitive moat: suppliers prefer Costco terms and are willing to offer better wholesale pricing in exchange for prompt payment.

Peloton's supplier stress signal. Before Peloton's financial collapse, the company's supplier financing programs expanded significantly as cash flow deteriorated. The disclosed increase in supplier financing was one of many red flags that the company's cash flow was under stress. The expansion ultimately could not be sustained, and Peloton had to cut supplier terms back, forcing a write-down of inventory and creating a working capital crisis.

Common mistakes when analyzing supplier financing disclosures

Assuming supplier financing is always bad. It is not. Extend payment terms can be efficient and mutually beneficial. Judge the practice in context: Is it growing aggressively? Is it concentrated among small suppliers? Is it accompanied by other working capital red flags?

Comparing supplier financing across industries without adjusting for norms. Retail operates on far different payment cycles than software. A 15% figure might be high for a tech company but normal for a distributor. Know the industry benchmarks before concluding that a disclosure is a red flag.

Ignoring the "material change" disclosure. The SEC requires disclosure of material changes in supplier financing terms quarter-to-quarter. If your company's disclosure mentions a "material change," read the details carefully. A shift from 90-day to 120-day terms, while subtle, can be the start of a troubling trend.

Forgetting that supplier financing and operating cash flow improvements can coincide with real operational gains. A company might improve inventory efficiency (real operational gain) while also extending supplier terms (financial engineering). Both can be true simultaneously. Do not assume that any supplier financing automatically invalidates the company's cash flow story; instead, adjust for the working capital component when assessing underlying operational cash flow.

FAQ

Q: Is supply chain financing (the reverse factoring kind) actually a win-win for suppliers? A: Only if the supplier has no better option. A supplier that can borrow from its own bank at 2% per annum should not use a 3-4% reverse factoring program to accommodate a customer's extended terms. But a small supplier with no access to low-cost capital might have no choice. The company effectively charges the supplier a 1-2% "tax" for the privilege of extended payment terms. This tax is invisible to investors but very real for the supplier.

Q: If a company needs supplier financing to manage its cash flow, does that mean the business is failing? A: Not necessarily. Some of the world's strongest companies use supplier financing as a legitimate cash management tool. The question is degree and trend. A 5-10% figure is normal; a 25% figure and growing faster than revenue is concerning. Additionally, if the company generates strong free cash flow independently, supplier financing is likely optional. If supplier financing is essential to achieve positive operating cash flow, the business is troubled.

Q: Can I compare supplier financing across two companies in different industries? A: Directly, no. Payment cycles vary by industry. But you can compare two companies in the same industry and draw conclusions. Within retail, within tech, within automotive, you can rank companies by supplier financing intensity and identify outliers.

Q: What if a company discloses supplier financing in its 10-K but not in its 10-Q? A: That is unusual and warrants a call to investor relations. The disclosure should be consistent across filings. If supplier financing appears in annual reports but not quarterly reports, the company may be burying the quarterly trends.

Q: How does supplier financing affect a company's credit rating? A: Rating agencies now factor supplier financing into their assessments of cash flow quality. A company that appears to generate $10 billion in operating cash flow but achieves $3 billion through supplier financing stretching is rated less favorably than a peer achieving $10 billion through genuine operations. Moody's and S&P both now scrutinize supplier financing disclosures.

Q: If I invest in a company that relies heavily on supplier financing, should I sell? A: Not automatically, but you should require the company to justify the practice and demonstrate it is not growing faster than revenue. Attend earnings calls and ask specific questions. Watch for supplier turnover or complaints in trade press. Make your decision based on total evidence, not on supplier financing alone.

Related concepts

• Working capital cycles and cash conversion: The interplay of receivables, inventory, and payables; supplier financing is one tool companies use to shorten this cycle artificially
• Operating cash flow quality: Comparing operating cash flow to net income and adjusting for working capital effects to assess the underlying health of cash generation
• Accounts payable and payment terms: The mechanics of how companies manage payables and the strategic implications of extending or shortening terms
• Supply chain management and competitive advantage: The relationship between payment terms, supplier relationships, and long-term competitive positioning
• Fair value measurement and contingent liabilities: How to assess whether supplier financing programs create hidden future obligations
• Small supplier risk and supply chain resilience: The concentration risk that emerges when large companies push payment obligations onto smaller suppliers

Summary

The SEC's 2023 ruling requiring disclosure of supplier financing arrangements has pulled back the curtain on one of corporate finance's oldest games: using extended payment terms and financial engineering to artificially boost cash flow while shifting burden onto suppliers. The new disclosures reveal the scale and growth rate of these programs, making it possible for investors to distinguish between companies that are operationally excellent and those that are simply squeezing suppliers.

A healthy cash flow comes from selling products, collecting payments, and generating profit. Supplier financing can accelerate this process modestly and legitimately, but aggressive supplier financing programs signal that underlying cash flow is weaker than headline numbers suggest. By examining the supplier financing disclosure in context—comparing it to peers, watching its growth rate, checking whether it exceeds industry norms, and questioning management in earnings calls—investors can identify which companies are genuinely strong and which are relying on financial engineering to mask operational weakness.

The strongest companies often have the lowest supplier financing intensity. They do not need to shift working capital burden onto suppliers because their own cash generation is sufficient. Conversely, companies that aggressively expand supplier financing programs are often revealing, through disclosure, the very weaknesses they are trying to hide.

Next

In the next article, we introduce a comprehensive cash flow quality checklist that brings together all the red flags, metrics, and analysis techniques from the past several articles, providing investors with a single diagnostic tool to assess the reliability and sustainability of any company's reported operating cash flow.

→ A cash flow quality checklist for investors